SAN JOSE, Calif., Oct. 13, 2016 -- Vocera Communications, Inc. (NYSE:VCRA) today announced that it expects to release results for its third quarter 2016 on Thursday, Oct. 27, after market close. In conjunction with a press release, management will host a conference call at 5 p.m. ET that afternoon.
A free, live webcast of the conference call will be available on the Investors section of the company’s website at investors.vocera.com.
The call also can be accessed by dialing 844-464-3152, or 508-637-5574 for international callers, and using the access code 81440273.
A replay of the call will be archived on the Vocera website.
About Vocera
Vocera Communications, Inc. offers the most robust clinical communications system in healthcare. Installed in more than 1,300 organizations worldwide, Vocera delivers secure, integrated and intelligent communication solutions that enable care teams to collaborate more efficiently by delivering the right information, to the right person, on the right device, in the right location, at the right time. Vocera solutions provide hands-free voice communication, secure text messaging, patient engagement tools, and integrated clinical workflow with EHRs, nurse call systems and physiological monitors. These solutions help improve operational efficiency, quality of care, safety and satisfaction across the continuum of care. In addition to technology solutions, Vocera drives thought leadership and new standards in care to elevate patient, family, nurse and physician experiences via the company's research collaborative, the Experience Innovation Network. Vocera is led by President and CEO Brent Lang and is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Canada, India, United Arab Emirates and the United Kingdom. Robert J. Zollars is the Chairman of the Board. For more information, visit www.vocera.com and @VoceraComm on Twitter.
The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.
CONTACTS: Investors and Analysts: Sue Dooley Vocera 408.882.5971 [email protected] Media: Amendola Communications for Vocera Tara Stultz 440.225.9595 [email protected]


Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



